The Rundown Meta Readies Fully Autonomous Ads, Moderna Rises on Next-Gen Covid-19 Vaccine Approval
18 snips
Jun 2, 2025 The stock market sees positive trends as earnings reports loom. Meta is revolutionizing small business ads with AI-driven innovations. Tesla's Model Y sales are soaring in Norway thanks to a new affordable version, while Moderna and BioNTech's market performance rises with FDA approvals. Rivian aims to tackle debt with a significant secured notes offering, despite a drop in share price. The podcast also dives into the surprising compensation of Axon Enterprise's CEO, shedding light on executive pay trends.
AI Snips
Chapters
Transcript
Episode notes
Meta's AI-Powered Ad Revolution
- Meta is developing AI tools to fully automate ad campaigns from a product photo to targeting.
- This will transform small business marketing and increase Meta's ad revenue significantly.
Tesla's Model 2 Confusion
- Tesla executives are uncertain if the $25,000 Model 2 car project is still active.
- Conflicting public statements from Elon Musk raise concerns about possible SEC issues.
Moderna's New COVID Vaccine Approved
- Moderna got FDA approval for its new COVID-19 vaccine targeting high-risk adults.
- This reflects ongoing concern over COVID as a serious health threat in 2024.